Overview
Announcements

Ordinary Rebalance | Solactive Healthcare Index | Effective Date 5th April 2024

In the ordinary rebalance, the following composition will be implemented effective open 05.04.2024:

ABBOTT LABORATORIES
ABBVIE INC
AGILENT TECHNOLOGIES INC
ALCON INC
AMGEN INC
ASTRAZENECA PLC
BECTON DICKINSON AND CO
BIOGEN INC
BRISTOL-MYERS SQUIBB CO
CENTENE CORP
CHUGAI PHARMACEUTICAL CO LTD ORD
CSL LTD ORD
DAIICHI SANKYO CO LTD ORD
DANAHER CORP
DEXCOM INC
EDWARDS LIFESCIENCES CORP
ELEVANCE HEALTH INC
ELI LILLY & CO
ESSILORLUXOTTICA
GE HEALTHCARE TECHNOLOGIES INC
GILEAD SCIENCES INC
GSK PLC
HCA HEALTHCARE INC
HOYA CORP ORD
HUMANA INC
IDEXX LABORATORIES INC
INTUITIVE SURGICAL INC
IQVIA HOLDINGS INC
JOHNSON & JOHNSON
LONZA GROUP AG
MEDTRONIC PLC
MERCK & CO. INC.
METTLER-TOLEDO INTL
MODERNA INC
NOVARTIS AG
NOVO NORDISK A/S
PFIZER INC
REGENERON PHARMACEUTICALS
RESMED INC
ROCHE HOLDING AG
SANOFI SA
STRYKER CORP
TAKEDA PHARMACEUTICAL
THE CIGNA GROUP
THERMO FISHER SCIENTIFIC INC
UNITEDHEALTH GROUP INC
VERTEX PHARMACEUTICALS INC
WEST PHARMACEUTICAL SERVICES INC
ZIMMER BIOMET HOLDINGS INC
ZOETIS INC